New Key Statistics Module, Z-Score and F-Score
NAS:ERNA Key Ratios
Market Cap $ M | 9.68 |
Enterprise Value $ M | 43.66 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.37 |
Price/Sales | 149.16 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -4.08 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.13 |
EV-to-EBITDA | -2.25 |
PEG | -- |
Shares Outstanding M | 5.41 |
Net Margin (%) | -31,864.71 |
Operating Margin % | -30,404.41 |
Pre-tax Margin (%) | -31,869.12 |
Quick Ratio | 1.46 |
Current Ratio | 1.46 |
ROA % (ttm) | -58.33 |
ROE % (ttm) | -371.69 |
ROIC % (ttm) | -67.92 |
Dividend Yield % | -- |
Altman Z-Score | -6.55 |
ERNA Number of Guru Trades
ERNA Volume of Guru Trades
Gurus Latest Trades with NAS:ERNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ERNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eterna Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ERNA
Total 0- 1